Fundraising Fox

Harpoon Therapeutics

South San Francisco, US · Delaware corporation · 3 known investors

harpoontx.com ↗
Biotechin /merck@Merck

Founders & leadership

JD
Jonathan DrachmanDirector
JV
Joanne VineyDirector
JB
Joseph BailesDirector
RH
Ronald HuntDirector
AR
Andrew RobbinsDirector
MC
Mark ChinDirector
LN
Luke Nathaniel WalkerExecutive Officer
JE
Julie EastlandExecutive Officer, Director
SM
Scott MyersDirector
LP
Lauren P. SilvernailDirector
AC
Alan ColowickDirector

Investors · 3

K2 HealthVenturesBoston · $10M – $100M
Taiho Ventures, LLCMenlo Park
MPM BioImpactreportedBoston · $1M – $15Mvia Luke Evnin · board

Reported raises · per SEC filings

Form D private placements
▶$100.2MraisedOct 2023 · 18 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew RobbinsDirector
  • Julie EastlandExecutive Officer, Director
  • Luke WalkerExecutive Officer
  • Mark ChinDirector
  • Scott MyersDirector
  • Jonathan DrachmanDirector
  • Ronald HuntDirector
  • Joseph BailesDirector
  • Lauren SilvernailDirector
Offering amount
$100.2M
Amount sold
$100.2M
Sales commissions
$6.4M
Placement agents
Cowen and Company, LLC, H.C. Wainwright & Co., LLC, Canaccord Genuity LLC
First sale
Oct 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25MraisedApr 2023 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan DrachmanDirector
  • Joanne VineyDirector
  • Joseph BailesDirector
  • Ronald HuntDirector
  • Andrew RobbinsDirector
  • Mark ChinDirector
  • Luke Nathaniel WalkerExecutive Officer
  • Julie EastlandExecutive Officer, Director
  • Scott MyersDirector
  • Lauren P. SilvernailDirector
  • Alan ColowickDirector
Offering amount
$25M
Amount sold
$25M
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$70MraisedNov 2018 · 17 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jonathan DrachmanDirector
  • Natalie R. SacksExecutive Officer
  • Julie EastlandDirector
  • Patrick BaeuerleDirector
  • Mark ChinDirector
  • Holger WescheExecutive Officer
  • Gerald McMahonExecutive Officer, Director
  • Scott MyersDirector
  • Ron HuntDirector
  • Georgia L. ErbezExecutive Officer
  • Luke EvninDirector
Offering amount
$70M
Amount sold
$70M
First sale
Nov 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$25.2MraisedJun 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ron HuntDirector
  • Mark ChinDirector
  • Patrick BaeuerleDirector
  • Gerald McMahonExecutive Officer, Director
  • Luke EvninDirector
  • Pablo CagnoniDirector
  • William E. PichtExecutive Officer
  • Dan HicklinDirector
Offering amount
$45.2M
Amount sold
$25.2M
First sale
May 2017
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.